Mitchell Timothy B, Dyer Kyle R, Peay Edmund R
National Addiction Centre, Institute of Psychiatry, King's College London, De Crespingy Park, London SE5 8AF, United Kingdom.
Subst Use Misuse. 2006;41(3):393-404. doi: 10.1080/10826080500409043.
Delivery of methadone maintenance treatment (MMT) varies considerably between service providers, but the reasons for this are unclear. This two-phase study involved a controlled investigation of factors that influence clinical decision making by methadone-prescribing physicians in regard to three decision-making scenarios: (1) individuals seeking induction into MMT and existing patients seeking (2) replacement and (2) takeaway methadone doses. In phase 1, physicians (n = 17) rated the diagnostic merit of 87 patient factors for each scenario. Ratings suggested that decisions are influenced by a range of subjective and "nonmedical" patient factors (e.g., contact with drug subculture, appearance, employment status, social support, having children), in addition to more conventional information sources regarding patients' medical and treatment status (e.g., being pregnant, urinalysis evidence of opioid and poly drug use, signs of opioid withdrawal). Phase 2 (n = 296) investigated relationships between physician characteristics and responses to randomized-controlled case vignettes (decisions and confidence ratings) in which the amount and type of diagnostic and nondiagnostic patient information was controlled. Vignette responses were significantly related to physician characteristics (e.g., professional orientation, location, and experience) independent of the patient information provided. Delivery of MMT may vary due to the diversity of patient factors that influence decisions and variability between physicians in the way such information is used to form judgments. Training programs for methadone prescribers should account for these sources of potential variability in treatment management.
美沙酮维持治疗(MMT)的实施在不同服务提供者之间差异很大,但其原因尚不清楚。这项分两阶段的研究对影响美沙酮处方医生临床决策的因素进行了对照调查,涉及三种决策场景:(1)寻求MMT诱导治疗的个体以及现有患者寻求(2)替代和(3)外带美沙酮剂量。在第一阶段,医生(n = 17)对每个场景下87个患者因素的诊断价值进行了评分。评分表明,除了关于患者医疗和治疗状况的更传统信息来源(例如怀孕、阿片类药物和多种药物使用的尿检证据、阿片类药物戒断迹象)之外,决策还受到一系列主观和“非医学”患者因素(例如与毒品亚文化的接触、外貌、就业状况、社会支持、有无子女)的影响。第二阶段(n = 296)调查了医生特征与对随机对照病例 vignette(决策和信心评分)的反应之间的关系,其中诊断性和非诊断性患者信息的数量和类型是可控的。vignette反应与医生特征(例如专业方向、地点和经验)显著相关,而与所提供的患者信息无关。MMT的实施可能因影响决策的患者因素的多样性以及医生在利用此类信息形成判断方式上的差异而有所不同。美沙酮处方医生的培训计划应考虑到治疗管理中这些潜在差异的来源。